相关实验视频

Updated: Jul 9, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

确定子宫内膜透明细胞癌的临床特征和分子特征

Yuhan Cai¹, Qin Han¹, Hongyan Guo¹

¹Department of Gynecology, Peking University Third Hospital, Beijing, China.

Frontiers in oncology

|December 4, 2023

概括

与子宫内膜癌相比,子宫内膜透明细胞癌 (ECCC) 显示出不同的临床特征和TCGA亚型. 在ECCC中,HER-2和TAF1表达损失与更糟糕的结果有关.

科学领域:

妇科瘤学妇科瘤学
病理学病理学病理学
分子诊断学分子诊断学

背景情况:

子宫内膜透明细胞癌 (ECCC) 是一种罕见的子宫内膜癌亚型.
了解其独特的临床和分子特征对于改善患者管理至关重要.

研究的目的:

在ECCC中验证癌症基因组图谱 (TCGA) 亚型.
确定ECCC的临床和分子特征,并与子宫内膜癌进行比较.

主要方法:

对28名ECCC和112名子宫内膜癌患者的临床数据进行比较分析.
在19个ECCC病例中对ER,PR,ARID1A,ARID1B,TAF1和HER-2进行TCGA分类和免疫组织化学 (IHC).
基于临床和分子标志物的患者结果的评估.

主要成果:

与子宫内膜癌相比,ECCC患者年龄较大,患有肌肉膜侵袭,淋巴血管空间侵袭 (LVSI) 和先进的FIGO阶段的比率更高.
在ECCC中,LVSI被确定为预后不佳的因素.
在ECCC中TCGA亚型包括POLEmut (10.5%),MMRd (15.8%),p53wt (57.9%) 和p53abn (15.8%).
在ECCC中观察到HER-2阳性表达 (31.6%) 和TAF1表达损失 (42.1%),两者都与较差的结果有关.

结论:

ECCC表现出独特的临床和分子形状,与子宫内膜癌不同.
TCGA亚型与不同的患者结果相关.
HER-2和TAF1可以作为ECCC的新预后标志物.

关键词:

在HER-2系统中,HER-2是HER-2.在TAF1中,TAF1是TAF1.在TCGA中,TCGA就是TCGA.这是子宫内膜透明细胞癌.分子特征分子特征.

更多相关视频

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...